Showing 141-150 of 263 results for "".
- William J. Link, PhD, Named Chairman of Allegro Ophthalmics’ Board of Directorshttps://modernod.com/news/william-j-link-phd-named-chairman-of-allegro-ophthalmics-board-of-directors/2479313/Allegro Ophthalmics announced that William J. Link, PhD, has been appointed chairman by the company’s board of directors and that Stephanie Yee was named vice president of finance. “I am thrilled that Bill has agreed to serve as our board chairman and pleased to promote Stephanie as VP of
- Ocuphire Announces Appointment of Jay S. Pepose, MD, PhD, to Its Board of Directorshttps://modernod.com/news/ocuphire-announces-appointment-of-jay-s-pepose-md-phd-to-its-board-of-directors/2479272/Ocuphire Pharma announced the appointment of Jay S. Pepose, MD, PhD, to its Board of Directors. Concurrent to Dr. Pepose’s appointment at Ocuphire’s annual shareholder meeting on June 7, Alan Meyer, MBA, retired from his role on the Board of Directors, having served since April 2018. “We a
- Ora Appoints David P. Bingaman, DVM, PhD, in Newly Created Chief Development Officer Positionhttps://modernod.com/news/ora-appoints-david-p-bingaman-dvm-phd-in-newly-created-chief-development-officer-position/2479097/Ora announced that David P. Bingaman, DVM, PhD, D. ACVO has joined the company in a newly created role of Chief Development Officer (CDO). Dr. Bingaman will oversee clinical and nonclinical activities that directly impact Ora’s customers around the world. Ora’s clinical research spans all
- Ocutrx Technologies Appoints Bill Link, PhD, as Chairman of the Ocutrx International Scientific Advisory Boardhttps://modernod.com/news/ocutrx-technologies-appoints-bill-link-phd-as-chairman-of-the-ocutrx-international-scientific-advisory-board/2478813/Ocutrx Technologies has announced the appointment of William “Bill” Link, PhD, as the chairman of the Ocutrx International Scientific Advisory Board. The board plays a key role in guiding and prioritizing Ocutrx’s global research and development investment, while serving as the gu
- Aerie Pharmaceuticals Announces Appointment of Michelle Senchyna, PhD, as Vice President, Clinical Development and Medical Affairshttps://modernod.com/news/aerie-pharmaceuticals-announces-appointment-of-michelle-senchyna-phd-as-vice-president-clinical-development-and-medical-affairs/2477271/Aerie Pharmaceuticals announced the appointment of Michelle Senchyna, PhD, as Vice President, Clinical Development and Medical Affairs, reporting to David A. Hollander, MD, MBA, Aerie’s Chief Research & Development Officer. Dr. Senchyna will lead and direct the clinical development and
- Iveric bio Appoints Guangping Gao, PhD, Internationally Recognized Gene Therapy Pioneer as Chief Strategist, Gene Therapyhttps://modernod.com/news/iveric-bio-appoints-guangping-gao-phd-internationally-recognized-gene-therapy-pioneer-as-chief-strategist-gene-therapy/2477122/Iveric bio announced the appointment of Guangping Gao, PhD, as Chief Strategist, Gene Therapy. Dr. Gao brings more than 30 years of scientific research experience in gene-based treatments. As one of the world’s leading gene therapy experts, Dr. Gao’s highly distinguished career includes major con
- Alan R. Morse, JD, PhD, Vision and Healthcare Services Innovator, Will Retire As President & CEO of Lighthouse Guildhttps://modernod.com/news/alan-r-morse-jd-phd-vision-and-healthcare-services-innovator-will-retire-as-president-ceo-of-lighthouse-guild/2476695/James M. Dubin, Chairman of the Board of Lighthouse Guild, announced that Alan R. Morse, JD, PhD, will be stepping down later this year as President & CEO of Lighthouse Guild after an extraordinary career of almost 52 years as a leader and innovator in the field
- 2019 Bressler Prize Awarded to Vladimir Kefalov, PhD, for Outstanding Accomplishments in Vision Science Researchhttps://modernod.com/news/2019-bressler-prize-awarded-to-vladimir-kefalov-phd-for-outstanding-accomplishments-in-vision-science-research/2476357/Lighthouse Guild announced that Vladimir Kefalov, PhD, has been awarded the 2019 Bressler Prize for his outstanding advances in vision science research. Dr. Kefalov is one of the leading retinal scientists in the world. His work has generated new insights into mecha
- BioAxone BioSciences’ Scientific Advisory Board Member, Mark Bear, PhD, Receives $500,000 Beckman-Argyros Vision Research Awardhttps://modernod.com/news/bioaxone-biosciences-scientific-advisory-board-member-mark-bear-phd-receives-500000-beckman-argyros-vision-research-award/2479937/BioAxone BioSciences announced that its Scientific Advisory Board member, Mark Bear, PhD, the Picower Professor of Neuroscience at the Massachusetts Institute of Technology, received the prestigious Arnold and Mabel Beckman Foundation 2018 Beckman-Argyros Vision Research Award. This annual
- Staar Surgical Names Warren Foust Chief Operating Officer; Magda Michna, PhD, Chief Clinical, Regulatory and Medical Affairs Officerhttps://modernod.com/news/staar-surgical-names-warren-foust-chief-operating-officer-magda-michna-phd-chief-clinical-regulatory-and-medical-affairs-officer/2481498/Staar Surgical announced that Warren Foust has been named Chief Operating Officer, and Magda Michna, PhD, has been named Chief Clinical, Regulatory and Medical Affairs Officer. Both positions will report to Staar Surgical’s President and CEO, Tom Frinzi. “The addition of two